EMAIL THIS PAGE TO A FRIEND

Biochimica et biophysica acta

Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system.


PMID 7947975

Abstract

Human prostaglandin G/H synthase 1 and 2 were expressed in the baculovirus expression system and purified to high levels. Both enzymes were glycosylated. PGHS-1 appeared to be homogeneous by SDS-PAGE analysis but two closely migrating bands were detected in PGHS-2 preparation which were evidently due to heterogeneity in glycosylation. The amino-acid sequence of the N-termini of both isoforms indicated that the signal sequences were efficiently cleaved by the insect cells. The recombinant human PGHS-1 and PGHS-2 possessed both cyclooxygenase and peroxidase activities. Both had high affinities for arachidonate as substrate and underwent self-inactivation during catalysis. The recombinant isoforms were not pharmacologically identical, since some NSAIDs were selective inhibitors of either PGHS-1 or PGHS-2. This is the first report of high levels of expression and purification of human PGHS isoforms. The recombinant enzymes are invaluable in developing potent PGHS-2 selective inhibitors that may be efficacious anti-inflammatory drugs with no or low levels of toxicity.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

284785
(S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid, 98%
C14H14O3
C0733 Cyclooxygenase 1 from sheep, glycerol solution, ≥30,000 units/mg protein
I4883
Ibuprofen, ≥98% (GC)
C13H18O2
I7905
Ibuprofen, meets USP testing specifications
C13H18O2
PHR1004
Ibuprofen, Pharmaceutical Secondary Standard; Certified Reference Material
C13H18O2
BP539
Ibuprofen, British Pharmacopoeia (BP) Reference Standard
C13H18O2
I0020000
Ibuprofen, European Pharmacopoeia (EP) Reference Standard
C13H18O2
1335508
Ibuprofen, United States Pharmacopeia (USP) Reference Standard
C13H18O2
I110
Ibuprofen
C13H18O2
Y0000881
Ibuprofen for peak identification, European Pharmacopoeia (EP) Reference Standard
C13H18O2
I1892
Ibuprofen sodium salt, analytical standard, ≥98% (GC)
C13H17NaO2
I7904
Indomethacin heptyl ester, methyl acetate solution, ≥98% (HPLC)
C26H30ClNO4
N8280
Naproxen, meets USP testing specifications
C14H14O3
46482
Naproxen, VETRANAL, analytical standard
C14H14O3
PHR1040
Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material
C14H14O3
BP435
Naproxen, British Pharmacopoeia (BP) Reference Standard
C14H14O3
N0250000
Naproxen, European Pharmacopoeia (EP) Reference Standard
C14H14O3
1457301
Naproxen, United States Pharmacopeia (USP) Reference Standard
C14H14O3
N5160
Naproxen sodium, meets USP testing specifications
C14H13NaO3
M1275
Naproxen sodium, 98.0-102.0%
C14H13NaO3
PHR1165
Naproxen sodium, Pharmaceutical Secondary Standard; Certified Reference Material
C14H13NaO3
1457403
Naproxen sodium, United States Pharmacopeia (USP) Reference Standard
C14H13NaO3
N0630
Niflumic acid
C13H9F3N2O2